Tag: Spark Therapeutics

A total of 5 posts are filed under Spark Therapeutics
Register Now for the Cell and Gene Exchange!
Please join Global Genes in attending the inaugural Cell & Gene Exchange May 22nd and 23rd co-produced by Alliance Regenerative Medicine… Continue Reading
Spark Therapeutics Launches Initiative to Improve Access to Genetic Testing for Inherited Retinal Diseases
Spark Therapeutics (NASDAQ: ONCE) will provide physicians and eligible patients access to genetic testing and counseling for more than 30… Continue Reading
Spark Therapeutics Announces Launch of aSharedVision, a New Online Resource to Unite and Inform Those Affected by Inherited Retinal Diseases
Spark Therapeutics today announced the launch of aSharedVision (www.aSharedVision.com), a new online resource designed to help patients,… Continue Reading
Spark Therapeutics Announces Results from Trial of SPK-RPE65 for Genetic Blinding Conditions
Spark Therapeutics today announced positive results from their Phase 3 pivotal trial for a gene therapy product looking to be used to treat… Continue Reading
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi as Chief Commercial Officer
Spark Therapeutics, a late-stage gene therapy company developing treatments for debilitating genetic diseases, announced today that it has… Continue Reading

Follow us on Twitter